Australian Retirement Trust exits substantial holder status in Integral Diagnostics

Integral Diagnostics Ltd. ( (AU:IDX) ) just unveiled an announcement.

Australian Retirement Trust Pty Ltd, acting as trustee for Australian Retirement Trust, has notified Integral Diagnostics that it has ceased to be a substantial shareholder in the company as of 19 May 2026. The change in relevant interest, detailed in a regulatory filing under the Corporations Act, indicates a reduction in the super fund’s holding below the substantial shareholder threshold, which may modestly alter the radiology provider’s institutional investor mix but does not signal any disclosed change in control or strategic direction.

The notice confirms there were no new or ceased associates linked to Australian Retirement Trust in relation to Integral Diagnostics’ voting securities. While transaction-level details are contained in an annexure, the filing primarily serves to update the market on movements in significant institutional ownership, a factor closely watched by investors monitoring liquidity, governance influence and potential shifts in shareholder support.

The most recent analyst rating on (AU:IDX) stock is a Buy with a A$3.20 price target. To see the full list of analyst forecasts on Integral Diagnostics Ltd. stock, see the AU:IDX Stock Forecast page.

More about Integral Diagnostics Ltd.

Integral Diagnostics Ltd is an Australian healthcare company that operates diagnostic imaging services, providing radiology and related medical imaging to hospitals, clinics and community referrers. The group focuses on delivering clinical imaging solutions that support diagnosis and treatment pathways across its regional and metropolitan networks.

Average Trading Volume: 980,087

Technical Sentiment Signal: Sell

Current Market Cap: A$760.6M

For detailed information about IDX stock, go to TipRanks’ Stock Analysis page.